List your tool

Head to head · 2026

Artera vs InformAI

Pricing, free plans, ratings, features, pros and cons, side by side. Where one comes out ahead, we mark it.

Artera

FDA-cleared multimodal AI that reads biopsy images and clinical data to guide cancer therapy decisions

4.4Not listed

Visit Artera (opens Artera in a new tab)

InformAI

Houston healthcare AI company with an FDA-cleared radiation therapy dose-planning tool and transplant and sinus-imaging products

3.9Not listed

Visit InformAI (opens InformAI in a new tab)

Who comes out ahead

Based only on the facts in our directory. The right pick still depends on the job you need done.

  • Lower starting price

    Not comparable

    Not comparable: Artera does not list a price

  • Free plan

    Tie

    Neither has one

  • Higher rating

    Artera

    4.4 against 3.9

  • Same job?

    Yes

    Both are Healthcare AI tools

Side by side

Compared onArteraInformAI
Our rating4.4Better3.9
Starts atNot listedNot listed
Free planNoNo
CategoryHealthcare AIHealthcare AI
PlansSee pricingSee pricing
Key features
  • Multimodal AI trained on digitized biopsy images paired with clinical data
  • FDA De Novo authorization for the ArteraAI Prostate Test
  • FDA clearance for ArteraAI Breast digital pathology risk stratification
  • Results delivered in as little as two days after sample submission
  • Inclusion in National Comprehensive Cancer Network (NCCN) treatment guidelines
  • RadOncAI radiation therapy dose planning with FDA 510(k) clearance
  • Focus on head and neck cancer treatment planning
  • TransplantAI donor-recipient informatics for transplant decisions
  • SinusAI CT diagnostics enhancement, in development
  • Peer-reviewed publication on transplant models
Pros
  • Regulatory clearance (FDA De Novo, NCCN guideline inclusion) beyond most AI health startups
  • Published clinical evidence showing improved outcome prediction versus existing risk models
  • Adopted by a meaningful share of US prostate cancer clinicians already
  • One product has FDA 510(k) clearance, a meaningful regulatory milestone
  • Peer-reviewed evidence published for the transplant work
  • Specific clinical problems rather than generic health AI
Cons
  • Not a self-serve software product; access runs through labs, clinicians, and insurance billing
  • Pricing is not public and varies by payer and region
  • Limited to prostate and breast cancer currently, not a general oncology platform
  • Only RadOncAI is described as cleared; the other products are research or in development
  • Enterprise-only, with no published pricing
  • Partner institutions are not named on the page
CompanyArtera, founded 2021InformAI

Prices come from each vendor's pricing page, last checked 20260921. Check the vendor before you buy.

FAQ

Questions people ask

Is Artera better than InformAI?

In our reviews Artera scores 4.4 and InformAI scores 3.9. The better pick depends on the job. Artera: FDA-cleared multimodal AI that reads biopsy images and clinical data to guide cancer therapy decisions. InformAI: Houston healthcare AI company with an FDA-cleared radiation therapy dose-planning tool and transplant and sinus-imaging products.

Which is cheaper, Artera or InformAI?

Artera: see pricing. InformAI: see pricing.

Do Artera and InformAI have free plans?

Neither lists a free plan.

More comparisons

Artera compared with

All Artera alternatives

InformAI compared with

All InformAI alternatives